Robotically assisted surgery involves a surgeon guiding the robot’s mechanical arms from a console to perform the surgery. The approach allows for smaller incisions than traditional surgery and is often used for prostate removals and hysterectomies.
Once launched, Medtronic’s robot will compete against Intuitive Surgical System’s da Vinci system, which is currently the only robot used for abdominal surgery on the market. The robotic system is also expected to compete with Verb Surgical, a startup backed by Johnson & Johnson, and Google’s startup Alphabet that also has a robot in development.
Medtronic hopes to lower the costs associated with robotic surgery through the new robotic system, which will launch in India.
The company expects the robot to make a meaningful contribution to its revenue in the 2019 fiscal year.
More articles on supply chain:
6 things to know about international cancer drug costs
Patient trials deem wearable artificial kidney viable prototype
Fentanyl: 7 things to know about the drug that killed Prince
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
